263 related articles for article (PubMed ID: 31757813)
1. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
Christersson C; James SK; Lindhagen L; Ahlsson A; Friberg Ö; Jeppsson A; Ståhle E
Heart; 2020 Jun; 106(11):838-844. PubMed ID: 31757813
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
3. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
4. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
Ke Y; Wang J; Wang W; Guo S; Dai M; Wu L; Bao Y; Li B; Ju J; Xu H; Jin Y
Int J Cardiol; 2022 Sep; 362():139-146. PubMed ID: 35654173
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
[TBL] [Abstract][Full Text] [Related]
7. Medium-Term Outcomes of the Different Antithrombotic Regimens After Transcatheter Aortic Valve Implantation.
Naser JA; Kucuk HO; Gochanour BR; Scott CG; Kennedy AM; Luis SA; Pislaru C; Greason KL; Crestanello JA; Gulati R; Eleid MF; Nkomo VT; Pislaru SV
Am J Cardiol; 2023 Jul; 198():113-123. PubMed ID: 37202327
[TBL] [Abstract][Full Text] [Related]
8. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
10. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
11. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
[TBL] [Abstract][Full Text] [Related]
12. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
[TBL] [Abstract][Full Text] [Related]
14. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis Comparing Single Versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.
Maes F; Stabile E; Ussia GP; Tamburino C; Pucciarelli A; Masson JB; Marsal JR; Barbanti M; Côté M; Rodés-Cabau J
Am J Cardiol; 2018 Jul; 122(2):310-315. PubMed ID: 29861051
[TBL] [Abstract][Full Text] [Related]
17. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
18. Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Whitlock RP; Eikelboom JW
J Am Coll Cardiol; 2012 Sep; 60(11):978-80. PubMed ID: 22921974
[No Abstract] [Full Text] [Related]
19. Comparative efficacy and safety of antithrombotic therapy for transcatheter aortic valve replacement: a systematic review and network meta-analysis.
Zhu Y; Zou Z; Huang Y; Zhang L; Chen H; Li Y; Liu C; Li X; Xu D; Zeng Q
Eur J Cardiothorac Surg; 2020 May; 57(5):965-976. PubMed ID: 31883333
[TBL] [Abstract][Full Text] [Related]
20. No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
Kobari Y; Inohara T; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
JACC Cardiovasc Interv; 2023 Jan; 16(1):79-91. PubMed ID: 36599591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
